| Mrs Ileana Irina Vintila, PMHNP-BC | |
|
268 Stillwater Ave, Bangor, ME 04401-3945 | |
| (800) 640-1211 | |
| Not Available |
| Full Name | Mrs Ileana Irina Vintila |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 268 Stillwater Ave, Bangor, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043945579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 2022001494 (Maine) | Primary |
| Entity Name | Bridgton Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154370153 PECOS PAC ID: 8123919099 Enrollment ID: O20040322000534 |
News Archive
Scientists from the Centenary Institute have developed a new therapeutic strategy that could potentially help the fight against advanced-stage melanoma.
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of neurodegenerative disorders.
In a report released today by the U.S. Department of Health and Human Services, an Independent Panel formed to review HHS's response to Ebola made several recommendations on how the nation's federal public health system should strengthen its response to major public health threats, both internationally and domestically.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
› Verified 6 days ago
| Entity Name | Acadia Hospital Corp. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215940523 PECOS PAC ID: 7719878495 Enrollment ID: O20040323000136 |
News Archive
Scientists from the Centenary Institute have developed a new therapeutic strategy that could potentially help the fight against advanced-stage melanoma.
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of neurodegenerative disorders.
In a report released today by the U.S. Department of Health and Human Services, an Independent Panel formed to review HHS's response to Ebola made several recommendations on how the nation's federal public health system should strengthen its response to major public health threats, both internationally and domestically.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
› Verified 6 days ago
| Entity Name | Central Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441 |
News Archive
Scientists from the Centenary Institute have developed a new therapeutic strategy that could potentially help the fight against advanced-stage melanoma.
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of neurodegenerative disorders.
In a report released today by the U.S. Department of Health and Human Services, an Independent Panel formed to review HHS's response to Ebola made several recommendations on how the nation's federal public health system should strengthen its response to major public health threats, both internationally and domestically.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
› Verified 6 days ago
| Entity Name | Sebasticook Valley Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457461477 PECOS PAC ID: 3476462797 Enrollment ID: O20040513001197 |
News Archive
Scientists from the Centenary Institute have developed a new therapeutic strategy that could potentially help the fight against advanced-stage melanoma.
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of neurodegenerative disorders.
In a report released today by the U.S. Department of Health and Human Services, an Independent Panel formed to review HHS's response to Ebola made several recommendations on how the nation's federal public health system should strengthen its response to major public health threats, both internationally and domestically.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
› Verified 6 days ago
| Entity Name | Rumford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205991122 PECOS PAC ID: 3870583511 Enrollment ID: O20040514000890 |
News Archive
Scientists from the Centenary Institute have developed a new therapeutic strategy that could potentially help the fight against advanced-stage melanoma.
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of neurodegenerative disorders.
In a report released today by the U.S. Department of Health and Human Services, an Independent Panel formed to review HHS's response to Ebola made several recommendations on how the nation's federal public health system should strengthen its response to major public health threats, both internationally and domestically.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ileana Irina Vintila, PMHNP-BC 1701 Edinburg Rd, Argyle Twp, ME 04468-7302 Ph: (301) 542-6791 | Mrs Ileana Irina Vintila, PMHNP-BC 268 Stillwater Ave, Bangor, ME 04401-3945 Ph: (800) 640-1211 |
News Archive
Scientists from the Centenary Institute have developed a new therapeutic strategy that could potentially help the fight against advanced-stage melanoma.
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of neurodegenerative disorders.
In a report released today by the U.S. Department of Health and Human Services, an Independent Panel formed to review HHS's response to Ebola made several recommendations on how the nation's federal public health system should strengthen its response to major public health threats, both internationally and domestically.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
› Verified 6 days ago
Diane M Hill, MSN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Northeast Dr, Bangor, ME 04401 Phone: 207-275-3800 Fax: 207-275-3803 | |
Nancy J Fishwick, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 30 Mckinley St, Bangor, ME 04401 Phone: 207-659-3690 | |
Kathrin G Hastey, FNPC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6 Telcom Dr, Bangor, ME 04401 Phone: 207-947-0147 Fax: 207-990-3365 | |
Judy Splittgerber, PMHNP-BC, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6 Telcom Dr Fl 2, Bangor, ME 04401 Phone: 207-947-0147 | |
Ms. Constance E Russell, FNPC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 268 Stillwater Avenue, Acadia Hospital Corp, Bangor, ME 04401 Phone: 207-973-6100 Fax: 207-973-6109 | |
Maegan L Woodman, FNPC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6 Telcom Dr Fl 2, Bangor, ME 04401 Phone: 207-947-0147 Fax: 207-990-3365 | |
Mrs. Alexandria Elizabeth Redmond, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 302 Husson Ave, #2, Bangor, ME 04401 Phone: 207-941-2373 Fax: 207-941-8803 |